Luca Costanzo

Dr. Luca Costanzo

Division of Angiology, Ferrarotto-Policlinic Hospital, University of Catania, Catania, Italy
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
LCLuca Costanzo
Luca Costanzo
FPFrancesco Paolo Palumbo
Francesco Paolo Palumbo
GAGiorgio Ardita
Giorgio Ardita
PAPier Luigi Antignani
Pier Luigi Antignani
EAEnrico Arosio
Enrico Arosio
GFGiacomo Failla
Giacomo Failla

Verified
Journal Article
Open access
PDF file
MMMarco Mangiafico
Marco Mangiafico
ACAndrea Caff
Andrea Caff
LCLuca Costanzo
Luca Costanzo
Coronavirus disease 2019 (COVID-19) is associated with an increased risk of venous thromboembolism (VTE) and coagulopathy, especially in critically ill patients. Endothelial damage induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is emerging as a crucial pathogenetic mechanism for the development of complications in an acute phase of the illness and for several postdischarge sequalae. Heparin has been shown to have a positive impact on COVID-19 due to its anticoagulant function. Moreover, several other biological actions of heparin were postulated: a potential anti-inflammatory and antiviral effect through the main protease (Mpro) and heparansulfate (HS) binding and a protection from the damage of vascular endothelial cells. In this paper, we reviewed available evidence on heparin treatment in COVID-19 acute illness and chronic sequalae, focusing on the difference between prophylactic and therapeutic dosage.

19 February 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
MMMarco Mangiafico
Marco Mangiafico
LCLuca Costanzo
Luca Costanzo
Superficial venous thrombosis (SVT), an inflammatory–thrombotic process of a superficial vein, is a relatively common event that may have several different underlying causes. This phenomenon has been generally considered benign, and its prevalence has been historically underestimated; the estimated incidence ranges from about 0.3 to 1.5 event per 1000 person-years, while the prevalence is approximately 3 to 11%, with different reports depending on the population studied. However, such pathology is not free of complications; indeed, it could extend to the deep circulation and embolize to pulmonary circulation. For this reason, an ultrasound examination is recommended to evaluate the extension of SVT and to exclude the involvement of deep circulation. Also, SVT may be costly, especially in the case of recurrence. Therefore, accurate management is necessary to prevent sequelae and costs related to the disease. This review aims to analyse the epidemiology of SVT, its complications, optimal medical treatment, and open questions with future perspectives.

10 December 2013 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
LCLuca Costanzo
Luca Costanzo
MCMaria Barbara Campisano
Maria Barbara Campisano
DCDavide Capodanno
Davide Capodanno
ASAndrea Sole
Andrea Sole
CGCarmelo Grasso
Carmelo Grasso
LPLuigi Di Pino
Luigi Di Pino

1 January 2021 in International Angiology
Verified
Journal Article
Closed access
LCLuca Costanzo
Luca Costanzo
GFGiacomo Failla
Giacomo Failla
PAPier L. Antignani
Pier L. Antignani
JFJawied Fareed
Jawied Fareed
YGYongquan Gu
Yongquan Gu
AMArmando Mansilha
Armando Mansilha
The SARS-CoV-2 infection (COVID-19) is causing an ongoing pandemic and potentially fatal disease. Development of coagulopathy with thrombotic complications such as deep vein thrombosis and pulmonary embolism are emerging as factors for progression to severe disease and death. Also, a markedly increased level of D-dimer, a protein product of fibrin degradation, has been associated to mortality. Furthermore, activation of immune response due to virus infection may led to uncontrolled severe inflammation with damage to host cells and induction of endotheliitis and cellular apoptosis and pyroptosis. The use of low molecular weight heparin in early stage of the disease could prevent vascular complications and reduce the progression to severe stage of the disease. Aim of this paper was to summarize current evidence about vascular involvement in COVID-19 disease and potential antithrombotic therapy.

6 April 2021 in Advanced Quantum Technologies
Verified
Journal Article
Open access
PDF file
NBNicola Biagi
Nicola Biagi
LCLuca Costanzo
Luca Costanzo
MBMarco Bellini
Marco Bellini
AZAlessandro Zavatta
Alessandro Zavatta
It is demonstrated that the recently developed technique of delocalized single photon addition may generate discorrelation, a new joint statistical property of multimode quantum light states, whereby the number of photons in each mode can take any value individually, but two modes together never exhibit the same. By coherently adding a single photon to two identical coherent states of light in different temporal modes, the first experimental observation of discorrelation is provided. The capability of manipulating this statistical property has applications in scenarios involving the secure distribution of information among untrusted parties, like in the so‐called “mental poker” games.